How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Pharma and Healthcare · Forecast 2027–2033
Infusion Pumps Software Market
- By Product Type: Volumetric Infusion Pumps, Syringe Pumps, Ambulatory Pumps, Elastomeric Pumps, Insulin Pumps
- By Software Type: Dose Error Reduction Software, Infusion Management Software, Remote Monitoring Software, Data Analytics and Reporting Software, Integration Software
- By End User: Hospitals, Ambulatory Care Centers, Home Healthcare, Long-term Care Facilities, Specialty Clinics
- By Application: Oncology, Anesthesia, Pain Management, Parenteral Nutrition, Diabetes Care
- By Connectivity Type: Wireless Connectivity, Wired Connectivity, Bluetooth Enabled, Wi-Fi Enabled, Cloud-based Solutions
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Projected to reach $X,XXX.XM by 2033 on sustained demand. Market Outlook →
- 03 Growth - X.XX% CAGR across 2027–2033, with the full year-by-year model inside. Market Outlook →
- 04 Leading segment - Volumetric Infusion Pumps leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 305 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.186 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.194 →
Full report · locked preview
Everything inside the Infusion Pumps Software Market report
A complete, evidence-based study - 12 chapters and 128 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Software Type 5
End User 5
Application 5
Connectivity Type 5
Companies profiled
Becton Dickinson and Company (BD)
Medtronic plc
Smiths Medical (a division of ICU Medical)
Fresenius Kabi
B. Braun Melsungen AG
Moog Inc.
Terumo Corporation
Nipro Corporation
Hospira (a Pfizer company)
CareFusion (acquired by BD)
Zhejiang Yuwell Medical Equipment & Supply Co. Ltd.
Sino Medical Sciences Technology Inc.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Becton Dickinson and Company (BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Smiths Medical (a division of ICU Medical)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Fresenius Kabi
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →B. Braun Melsungen AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Moog Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Terumo Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Nipro Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Hospira (a Pfizer company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →CareFusion (acquired by BD)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Zhejiang Yuwell Medical Equipment & Supply Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Sino Medical Sciences Technology Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Mindray Medical International Limited
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Nihon Kohden Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Roche Diagnostics
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →
Global · 2025–2033
$7,863M by 2033 · 10.0% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Volumetric Infusion Pumps31.7
- Syringe Pumps18.8
- Ambulatory Pumps21.0
- Elastomeric Pumps13.2
- Insulin Pumps15.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,209M → $2,536M · 9.7%
Europe$842.8M → $1,986M · 11.3%
Asia Pacific$769.5M → $1,737M · 10.7%
Latin America$476.4M → $1,059M · 10.5%
Middle East and Africa$366.4M → $851.8M · 11.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.972026
9.982027
9.982028
10.012029
10.012030
10.042031
10.052032
10.052033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Becton Dickinson and Company (BD)23.1
- Medtronic plc20.1
- Smiths Medical (a division of ICU Medical)10.9
- Fresenius Kabi4.0
- B. Braun Melsungen AG7.1
- Moog Inc.6.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type24.0%
Software Type15.7%
End User15.4%
Application33.4%
Connectivity Type11.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.0
- Europe24.3
- Asia Pacific21.3
- Latin America13.0
- Middle East and Africa10.4
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Becton Dickinson and Company (BD) | 89 | 95 | 73 | 97 | 96 | 78 | 88 |
| Medtronic plc | 68 | 74 | 84 | 85 | 91 | 87 | 82 |
| Smiths Medical (a division of ICU Medical) | 65 | 84 | 64 | 66 | 76 | 65 | 70 |
| Fresenius Kabi | 82 | 57 | 68 | 70 | 74 | 71 | 70 |
| B. Braun Melsungen AG | 59 | 55 | 61 | 53 | 61 | 57 | 58 |
| Moog Inc. | 70 | 51 | 60 | 55 | 48 | 55 | 57 |
| Terumo Corporation | 45 | 52 | 60 | 52 | 56 | 65 | 55 |
| Nipro Corporation | 42 | 36 | 37 | 53 | 49 | 46 | 44 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Becton Dickinson and Company (BD)
- Medtronic plc
- Smiths Medical (a division of ICU Medical)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Becton Dickinson and Company (BD) | ✓ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Medtronic plc | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Smiths Medical (a division of ICU Medical) | ✓ | ✓ | − | ✓ | ◐ | ◐ |
| Fresenius Kabi | ✓ | − | ◐ | − | ◐ | − |
| B. Braun Melsungen AG | ◐ | − | − | − | ◐ | ◐ |
| Moog Inc. | − | − | ✓ | − | − | ◐ |
| Terumo Corporation | − | − | ◐ | − | − | − |
| Nipro Corporation | − | − | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Becton Dickinson and Company (BD)88
2Medtronic plc82
3Smiths Medical (a division of ICU Medical)70
4Fresenius Kabi70
5B. Braun Melsungen AG58
6Moog Inc.57
7Terumo Corporation55
8Nipro Corporation44
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Becton Dickinson and Company (BD)Medtronic plc
Challenger2
Strong scale, closing on the leaders.
Smiths Medical (a division of ICU Medical)Fresenius Kabi
Contender2
Focused players with pockets of strength.
B. Braun Melsungen AGMoog Inc.
Niche2
Specialists in a single segment or region.
Terumo CorporationNipro Corporation
Go-to-market strategy
Land Product Type in North America, then scale across Infusion Pumps Software Market — a $303M beachhead inside a $4.68B market.
Beachhead (SOM)$303Mobtainable near-term
Serviceable (SAM)$1.95Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Volumetric Infusion Pumps
Best fit — highest urgency & budget in Product Type.
Economic buyer78 fit
Syringe Pumps
Strong fit — clear ROI and a fast path to value.
End user65 fit
Ambulatory Pumps
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Software Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales41%
Partner / channel30%
Digital / self-serve22%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Infusion Pumps Software Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified23%
Evaluation12%
Closed-won8%
$9.9KCAC
$55KLTV
5.5:1LTV : CAC
< 4 moCAC payback
Investment thesis
Infusion Pumps Software Market is a resilient opportunity — $7.05B by 2033, compounding at 5.9%.
TAM · 2025$4.46Btoday
TAM · 2033$7.05Bforecast
CAGR5.9%2027–2033
Cumulative$51.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.05BTotal addressable market
SAM$2.48BServiceable available market
SOM$442MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.9% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.05BLarge & growingTAM by 2033 at 5.9% CAGR
$2.48BServiceable nowreachable with today’s model
$442MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.50BBear3.8% CAGR
$7.05BBase5.9% CAGR
$9.03BBull7.8% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Software Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Infusion Pumps Software Market — a $3.08B market by 2033. Plan: grow share from 7.4% to 14.4%.
Market size · 2033$3.08Btotal addressable
Market CAGR6.2%2027–2033
Target share14.4%from 7.4% today
Revenue ambition$443Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.4% | 14.4% | At risk |
| Revenue | $239M | $443M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 36.9% | 40.3% | Ahead |
| Customer retention | 88.4% | 95.8% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Software Type capability
A defensible second engine — invest in Software Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Software Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $63M capacity & capability investment
- Greenlight bolt-on M&A in Software Type
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentAhead
Sales deck · value proposition
Win the Infusion Pumps Software Market conversation — a $7.81B market you can size, segment and defend in minutes.
Market size · 2033$7.81Btotal opportunity
Growth4.7%CAGR to 2033
Addressable buyers1,176+accounts in scope
Typical ROI6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6×return on cost, year one
< 3 mopayback period
$47K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Becton Dickinson and Company (BD)Medtronic plcSmiths Medical (a division of ICU Medical)Fresenius KabiB. Braun Melsungen AGMoog Inc.Terumo CorporationNipro Corporation+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Infusion Pumps Software Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Infusion Pumps Software Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Pharma and Healthcare · scroll →Aconitine Market
Market size, share, segmentation and regional forecast.
$13.1B by 2031 · 6.91% CAGR
View reportPractice Management System Market
Market size, share, segmentation and regional forecast.
$7.9B by 2031 · 7.84% CAGR
View reportAcetoacet-o-Toludide Market
Market size, share, segmentation and regional forecast.
$9.4B by 2032 · 8.24% CAGR
View reportAceglutamide for Injection Market
Market size, share, segmentation and regional forecast.
$14.6B by 2031 · 5.59% CAGR
View reportTemperature Controlled Packaging Solutions for Pharmaceuticals Market
Market size, share, segmentation and regional forecast.
$14.4B by 2032 · 8.66% CAGR
View reportCapsule Hotel Market
Market size, share, segmentation and regional forecast.
$14.7B by 2032 · 8.73% CAGR
View reportCorrective And Preventive Action (CAPA) Software Market
Market size, share, segmentation and regional forecast.
$729M by 2033 · 8.88% CAGR
View report4K Endoscopic Camera System Market
Market size, share, segmentation and regional forecast.
$7.5B by 2031 · 9.78% CAGR
View reportHospital Lightings Market
Market size, share, segmentation and regional forecast.
$7.7B by 2031 · 5.14% CAGR
View reportPharmacy Benefit Manager (PBM) Market
Market size, share, segmentation and regional forecast.
$11.7B by 2033 · 9.17% CAGR
View report3D Printed Clear Dental Aligner Market
Market size, share, segmentation and regional forecast.
$3.0B by 2031 · 8.55% CAGR
View reportComputerized Physician Order Entry (CPOE) Systems Market
Market size, share, segmentation and regional forecast.
$8.0B by 2032 · 10.69% CAGR
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.